GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses-Reference-Cited by-同舟云学术

GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses

Published:2015-10-29 Issue:4 Volume:5 Page:e1101204
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kwek Serena S.,Kahn James,Greaney Samantha K.,Lewis Jera,Cha Edward,Zhang Li,Weber Robert W.,Leonard Lonnie,Markovic Svetomir N.,Fong Lawrence,Spitler Lynn E.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1101204

Reference35 articles.

1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2. Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma

3. From the Food and Drug Administration

4. Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions.

5. Induction of Macrophage Tumoricidal Activity by Granulocyte-Macrophage Colony-Stimulating Factor

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans;2024-07-16

2. Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer;Cancers;2024-01-24

3. Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors;Cancer Biology & Medicine;2023-11-06

4. Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins;iScience;2023-08

5. Macrophage’s role in solid tumors: two edges of a sword;Cancer Cell International;2023-07-31